FDA orders starker warnings on opioid painkillers
WASHINGTON (AP) — The Food and Drug Administration is requiring stronger warning labels on prescription painkillers like OxyContin, in the government's latest attempt to reduce overdose deaths caused by the long-acting medications. The changes announced Tuesday are designed to remind doctors and patients about the fatal risks of misusing and abusing long-acting opioid pain relievers, which include forms of oxycodone, morphine and other narcotic medications. Whereas the previous label recommended the medications for "moderate to severe pain," the new label describes a more limited role. It says the drugs should only be used for "pain severe enough to require daily, around-the-clock" treatment that cannot be managed with alternatives, such as over-the-counter medications or immediate-release opioids.
- CFO Exchange: Smartphones Poised to Disrupt Healthcare, Says Topol
- CNO on Hospital Redesign: 'You Can't Over-Communicate'
- Consumerism Drives Healthcare Branding, Rebranding Efforts
- How Digital Strategy Shapes Patient Engagement at Boston Children's Hospital
- PA Ranks See 'Phenomenal Growth,' Lack of Diversity
- Half of All Primary Care, Internal Medicine Jobs Unfilled in 2013
- 3 Traits Personality Assessments Can't Reveal
- Carondelet to Pay $35M to Settle Fraud Allegations
- Antibiotic Overuse a 'Huge Threat' to Patient Safety, Says CDC
- Cleveland Clinic Partners with North Shore-LIJ for Heart Care